Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Nov 1.

Published in final edited form as: Gastroenterology. 2019 Jul 11;157(5):1245–1252.e3. doi: 10.1053/j.gastro.2019.07.006

Figure 1. — Survival in patients with significant comorbidity (Charslon Comorbidity Index > 2) (dashed line) vs. mild comorbidity (Charlson Comorbidity Index ≤ 2) (solid line) using the Kaplan-Meier method in patients with suspected drug-induced liver injury (DILI) in the Indiana University Cohort (Figure 1-A) and University of North Carolina cohort (Figure 1-B).

Figure 1. — Survival in patients with significant comorbidity (Charslon Comorbidity Index > 2) (dashed line) vs. mild comorbidity (Charlson Comorbidity Index ≤ 2) (solid line) using the Kaplan-Meier method in patients with suspected drug-induced liver injury (DILI) in the Indiana University Cohort (Figure 1-A) and University of North Carolina cohort (Figure 1-B).